{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:07:46Z","timestamp":1767650866277},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1007\/bf02984560","type":"journal-article","created":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T08:44:12Z","timestamp":1226047452000},"page":"453-461","source":"Crossref","is-referenced-by-count":109,"title":["Significance of123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson\u2019s disease and related disorders: It can be a specific marker for Lewy body disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Junichi","family":"Taki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Yoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihisa","family":"Tonami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02984560_CR1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/BF00812368","volume":"17","author":"J Taki","year":"1990","unstructured":"Taki J, Nakajima K, Bunko H, Simizu M, Muramori A, Hisada K. Whole-body distribution of iodine 123 metaiodobenzylguanidine in hypertrophic cardiomyopathy: significance of its washout from the heart.Eur J Nucl Med 1990; 17: 264\u2013268.","journal-title":"Eur J Nucl Med"},{"key":"BF02984560_CR2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/BF00173491","volume":"20","author":"I Matsunari","year":"1993","unstructured":"Matsunari I, Bunko H, Taki J, Nakajima K, Muramori A, Kuji I, et al. Regional uptake of iodine-125-metaiodobenzylguanidine in the rat heart.Eur J Nucl Med 1993; 20: 1104\u20131107.","journal-title":"Eur J Nucl Med"},{"key":"BF02984560_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00006231-199405000-00003","volume":"15","author":"K Nakajima","year":"1994","unstructured":"Nakajima K, Taki J, Tonami N, Hisada K. Decreased123IMIBG uptake and increased clearance in various cardiac diseases.Nucl Med Commun 1994; 15: 317\u2013323.","journal-title":"Nucl Med Commun"},{"key":"BF02984560_CR4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/diab.44.5.543","volume":"44","author":"G Kreiner","year":"1995","unstructured":"Kreiner G, Wolzt M, Fasching P, Leitha T, Edlmayer A, Korn A, et al. Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function.Diabetes 1995; 44: 543\u2013549.","journal-title":"Diabetes"},{"key":"BF02984560_CR5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/0735-1097(94)00459-4","volume":"25","author":"A Langer","year":"1995","unstructured":"Langer A, Freeman MR, Josse RG, Armstrong PW. Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomie dysfunction and silent myocardial ischemia.JAm Coll Cardiol 1995; 25: 610\u2013618.","journal-title":"JAm Coll Cardiol"},{"key":"BF02984560_CR6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0735-1097(97)00159-9","volume":"30","author":"K Sakata","year":"1997","unstructured":"Sakata K, Shirotani M, Yoshida H, Kurata Iodine-123 metaiodobenzylguanidine cardiac imaging to identify and localize vasospastic angina without significant coronary artery narrowing.J Am Coll Cardiol 1997; 30: 370\u2013376.","journal-title":"J Am Coll Cardiol"},{"key":"BF02984560_CR7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03164811","volume":"11","author":"N Tamaki","year":"1997","unstructured":"Tamaki N, Tadamura E, Kudoh T, Hattori N, Inubushi M, Konishi J. Recent advances in nuclear cardiology in the study of coronary artery disease.Ann Nucl Med 1997; 11: 55\u201366.","journal-title":"Ann Nucl Med"},{"key":"BF02984560_CR8","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/01.CIR.101.22.2579","volume":"101","author":"I Matsunari","year":"2000","unstructured":"Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes.Circulation 2000; 101: 2579\u20132585.","journal-title":"Circulation"},{"key":"BF02984560_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF02988692","volume":"14","author":"M Momose","year":"2000","unstructured":"Momose M, Kobayashi H, Ikegami H, Matsuda N, Hachida M, Kasanuki H, et al. Regional cardiac sympathetic reinner-vation in transplanted human hearts detected byI23I-MIBG SPECT imaging.Ann Nucl Med 2000; 14: 333\u2013337.","journal-title":"Ann Nucl Med"},{"key":"BF02984560_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/BF02988288","volume":"14","author":"H Naruse","year":"2000","unstructured":"Naruse H, Arii T, Kondo T, Ohnishi M, Sakaki T, Takahashi K, et al. Relation between myocardial response to dobutamine stress and sympathetic nerve activation in patients with idiopathic dilated cardiomyopathy: a comparison of123I- MIBG scintigraphic and echocardiographic data.Ann Nucl Med 2000; 14: 427\u2013432.","journal-title":"Ann Nucl Med"},{"key":"BF02984560_CR11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF02987853","volume":"14","author":"Yoshida H Sakata","year":"2000","unstructured":"Sakata Yoshida H, Nawada R, Obayashi K, Tamekiyo H, Mochizuki M. Scintigraphic assessment of regional cardiac sympathetic nervous system in patients with single-vessel coronary artery disease.Ann Nucl Med 2000; 14: 151\u2013158.","journal-title":"Ann Nucl Med"},{"key":"BF02984560_CR12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02988236","volume":"15","author":"K Koyama","year":"2001","unstructured":"Koyama K, Inoue T, Hasegawa A, Oriuchi N, Okamoto E, Tomara Y, et al. Alternating myocardial sympathetic neural function of athlete\u2019s heart in professional cycle racers examined with iodine-123-MIBG myocardial scintigraphy.Ann Nucl Med 2001; 15: 307\u2013312.","journal-title":"Ann Nucl Med"},{"key":"BF02984560_CR13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF02988246","volume":"15","author":"S Matsuo","year":"2001","unstructured":"Matsuo S, Nakamura Y, Matsui T, Matsumoto T, Kinoshita M. Detection of denervated but viable myocardium in cardiac sarcoidosis with 1-123 MIBG and Tl-201 SPECT imaging.Ann Nucl Med 2001; 15: 373\u2013375.","journal-title":"Ann Nucl Med"},{"key":"BF02984560_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF02995289","volume":"16","author":"S Nagamachi","year":"2002","unstructured":"Nagamachi S, Jinnouchi S, Kurose T, Nishii R, Kawai K, Futami S, et al. Serial change inI23I-MIBG myocardial scintigraphy in non-insulin-dependent diabetes mellitus.Ann Nucl Med 2002; 16: 33\u201338.","journal-title":"Ann Nucl Med"},{"key":"BF02984560_CR15","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1067\/mnc.2002.128457","volume":"9","author":"J Narula","year":"2002","unstructured":"Narula J, Zaret BL. Epilogue: development of novel imaging techniques for ultimately superior management of congestive heart failure.J Nucl Cardiol 2002; 9: 81S-86S.","journal-title":"J Nucl Cardiol"},{"key":"BF02984560_CR16","first-page":"15","volume":"43","author":"M Shimizu","year":"2002","unstructured":"Shimizu M, Ino H, Yamaguchi M, Terai H, Hayashi Nakajima et al. Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy.J Nucl Med 2002; 43: 15\u201320.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0165-1838(94)90023-X","volume":"49","author":"S Hakusui","year":"1994","unstructured":"Hakusui S, Yasuda T, Yanagi T, Tohyama J, Hasegawa Y, Koike Y, et al. A radiological analysis of heart sympathetic functions with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure.J Auton Nerv Syst 1994; 49: 81\u201384.","journal-title":"J Auton Nerv Syst"},{"key":"BF02984560_CR18","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(94)90113-9","volume":"343","author":"Y Ando","year":"1994","unstructured":"Ando Y, Obayashi Tanaka Y, Tsuji T, Uchino M, Takahashi M, et al. Radiolabelled metaiodobenzylguanidine in assessment of autonomie dysfunction.Lancet 1994; 343: 984\u2013985.","journal-title":"Lancet"},{"key":"BF02984560_CR19","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0735-1097(88)90382-8","volume":"12","author":"GS Francis","year":"1988","unstructured":"Francis GS. Modulation of peripheral sympathetic nerve transmission.J Am Coll Cardiol 1988; 12: 250\u2013254.","journal-title":"J Am Coll Cardiol"},{"key":"BF02984560_CR20","first-page":"22","volume":"22","author":"DM Wieland","year":"1981","unstructured":"Wieland DM, Brown LE, Rogers WL, Worthington Wu JL, Clinthorne NH, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog.J Nucl Med 1981; 22: 22\u201331.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR21","first-page":"84","volume":"27","author":"M Nakajo","year":"1986","unstructured":"Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tanoue P, et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart.J Nucl Med 1986; 27: 84\u201389.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR22","first-page":"897","volume":"26","author":"MC Tobes","year":"1985","unstructured":"Tobes MC, Jaques S Jr, Wieland DM, Sisson JC. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.J Nucl Med 1985; 26: 897\u2013907.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR23","first-page":"1444","volume":"33","author":"MW Dae","year":"1992","unstructured":"Dae MW, De Marco T, Botvinick EH, O\u2019Connell JW, Hattner RS, Huberty JP, et al. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts\u2014implications for clinical studies.J Nucl Med 1992; 33: 1444\u20131450.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR24","first-page":"57","volume":"34","author":"D Fagret","year":"1993","unstructured":"Fagret D, Wolf JE, Vanzetto G, Borrel E. Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis.J Nucl Med 1993; 34: 57\u201360.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR25","first-page":"1625","volume":"28","author":"JC Sisson","year":"1987","unstructured":"Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.J Nucl Med 1987; 28: 1625\u20131636.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR26","first-page":"1194","volume":"24","author":"WM Manger","year":"1983","unstructured":"Manger WM, Hoffman BB. Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake.J Nucl Med 1983; 24: 1194\u20131196.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR27","first-page":"1182","volume":"30","author":"JV Glowniak","year":"1989","unstructured":"Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants.J Nucl Med 1989; 30: 1182\u20131191.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR28","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0002-8703(91)90671-4","volume":"121","author":"JC Sisson","year":"1991","unstructured":"Sisson JC, Bolgos G, Johnson J. Measuring acute changes in adrenergic nerve activity of the heart in the living animal.Am Heart J 1991; 121: 1119\u20131123.","journal-title":"Am Heart J"},{"key":"BF02984560_CR29","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.93.9.1667","volume":"93","author":"G Eisenhofer","year":"1996","unstructured":"Eisenhofer G, Friberg P, Rundqvist B, Quyyumi AA, Lambert G, Kaye DM, et al. Cardiac sympathetic nerve function in congestive heart failure.Circulation 1996; 93: 1667\u20131676.","journal-title":"Circulation"},{"issue":"3","key":"BF02984560_CR30","first-page":"III\/15","volume":"249","author":"O Riess","year":"2002","unstructured":"Riess O, Kruger R, Schulz JB. Spectram of phenotypes and genotypes in Parkinson\u2019s disease.J Neurol 2002; 249 Suppl 3: III\/15\u201320.","journal-title":"J Neurol"},{"key":"BF02984560_CR31","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","volume":"51","author":"WR Gibb","year":"1988","unstructured":"Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson\u2019s disease.J Neurol Neurosurg Psychiatry 1988; 51: 745\u2013752.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1440-1789.2001.00403.x","volume":"21","author":"H Takahashi","year":"2001","unstructured":"Takahashi H, Wakabayashi K. The cellular pathology of Parkinson\u2019s disease.Neuropathology 2001; 21: 315\u2013322.","journal-title":"Neuropathology"},{"issue":"3","key":"BF02984560_CR33","doi-asserted-by":"crossref","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak H, Del Tredici Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages).J Neurol 2002; 249 Suppl 3: III\/1\u20135.","journal-title":"J Neurol"},{"key":"BF02984560_CR34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease.Neurobiol Aging 2003; 24: 197\u2013211.","journal-title":"Neurobiol Aging"},{"key":"BF02984560_CR35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, Rub U, Gai WP, Del Tredici Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen.J Neural Transm 2003; 110: 517\u2013536.","journal-title":"J Neural Transm"},{"issue":"2","key":"BF02984560_CR36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000113469","volume":"38","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H. Neuropathology of autonomie nervous system in Parkinson\u2019s disease.Eur Neurol 1997; 38 Suppl 2: 2\u20137.","journal-title":"Eur Neurol"},{"key":"BF02984560_CR37","first-page":"609","volume":"60","author":"K Wakabayashi","year":"1993","unstructured":"Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F. Lewy bodies in the visceral autonomie nervous system in Parkinson\u2019s disease.Adv Neurol 1993; 60: 609\u2013612.","journal-title":"Adv Neurol"},{"key":"BF02984560_CR38","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.52.6.1269","volume":"52","author":"K Iwanaga","year":"1999","unstructured":"Iwanaga K, Wakabayashi K, Yoshimoto M, Tornita I, Satoh H, Takashima H, et al. Lewy body-type degeneration in cardiac plexus in Parkinson\u2019s and incidental Lewy body diseases.Neurology 1999; 52: 1269\u20131271.","journal-title":"Neurology"},{"key":"BF02984560_CR39","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1212\/WNL.57.6.1140","volume":"57","author":"S Orimo","year":"2001","unstructured":"Orimo S, Ozawa E, Oka T, Nakade S, Tsuchiya K, Yoshimoto M, et al. Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA.Neurology 2001; 57: 1140\u20131141.","journal-title":"Neurology"},{"key":"BF02984560_CR40","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jnnp.73.6.776","volume":"73","author":"S Orimo","year":"2002","unstructured":"Orimo S, Oka T, Miura H, Tsuchiya K, Mori F, Wakabayashi K, et al. Sympathetic cardiac denervation in Parkinson\u2019s disease and pure autonomie failure but not in multiple system atrophy.J Neurol Neurosurg Psychiatry 2002; 73: 776\u2013777.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00006231-199802000-00007","volume":"19","author":"M Yoshita","year":"1998","unstructured":"Yoshita M, Hayashi M, Hirai S. Decreased myocardial accumulation of123I-meta-iodobenzyl guanidine in Parkinson\u2019s disease.Nucl Med Commun 1998; 19: 137\u2013142.","journal-title":"Nucl Med Commun"},{"key":"BF02984560_CR42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s002590050544","volume":"27","author":"J Taki","year":"2000","unstructured":"Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M, et al. Peripheral sympathetic dysfunction in patients with Parkinson\u2019s disease without autonomie failure is heart selective and disease specific.Eur J Nucl Med 2000; 27: 566\u2013573.","journal-title":"Eur J Nucl Med"},{"key":"BF02984560_CR43","first-page":"71","volume":"41","author":"H Takatsu","year":"2000","unstructured":"Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson\u2019s disease: clinical and experimental studies with radiolabeled MIBG.J Nucl Med 2000; 41: 71\u201377.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-510X(00)00279-3","volume":"175","author":"A Druschky","year":"2000","unstructured":"Druschky A, Hilz MJ, Platsch G, Radespiel-Troger M, Druschky K, Kuwert T, et al. Differentiation of Parkinson\u2019s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.J Neurol Sci 2000; 175: 3\u201312.","journal-title":"J Neurol Sci"},{"key":"BF02984560_CR45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.74.4.423","volume":"74","author":"K Hamada","year":"2003","unstructured":"Hamada K, Hirayama M, Watanabe H, Kobayashi R, Ito H, leda T, et al. Onset age and severity of motor impairment are associated with reduction of myocardial123I-MIBG uptake in Parkinson\u2019s disease.J Neurol Neurosurg Psychiatry 2003; 74: 423\u2013426.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-0404.1998.tb05958.x","volume":"97","author":"S Braune","year":"1998","unstructured":"Braune S, Reinhardt M, Bathmann J, Krause T, Lehmann M, Lucking CH. Impaired cardiac uptake of meta-[l23I]iodobenzylguanidine in Parkinson\u2019s disease with autonomic failure.Acta Neurol Scand 1998; 97: 307\u2013314.","journal-title":"Acta Neurol Scand"},{"key":"BF02984560_CR47","first-page":"1020","volume":"53","author":"S Braune","year":"1999","unstructured":"Braune S, Reinhardt M, Schnitzer R, Riedel A, Lucking CH. Cardiac uptake of [123I]MIBG separates Parkinson\u2019s disease from multiple system atrophy.Neurobgy 1999; 53: 1020\u20131025.","journal-title":"Neurobgy"},{"key":"BF02984560_CR48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"S Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease.J Neurol Neurosurg Psychiatry 1999; 67: 189\u2013194.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR49","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/mds.10461","volume":"18","author":"F Courbon","year":"2003","unstructured":"Courbon F, Brefel-Courbon C, Thalamas C, Alibelli MJ, Berry I, Montastruc JL, et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson\u2019s disease.Mov Disord 2003; 18: 890\u2013897.","journal-title":"Mov Disord"},{"key":"BF02984560_CR50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","volume":"155","author":"M Yoshita","year":"1998","unstructured":"Yoshita M. Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supra-nuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.J Neurol Sci 1998; 155: 60\u201367.","journal-title":"J Neurol Sci"},{"key":"BF02984560_CR51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0404.1998.tb05957.x","volume":"97","author":"K Iwasa","year":"1998","unstructured":"Iwasa K, Nakajima K, Yoshikawa H, Tada A, Taki J, Takamori M. Decreased myocardial123I-MIBG uptake in Parkinson\u2019s disease.Acta Neurol Scand 1998; 97: 303\u2013306.","journal-title":"Acta Neurol Scand"},{"key":"BF02984560_CR52","first-page":"371","volume":"40","author":"A Satoh","year":"1999","unstructured":"Satoh A, Serita T, Seto M, Tornita I, Satoh H, Iwanaga K. et al. Loss ofI23I-MIBG uptake by the heart in Parkinson\u2019s disease: assessment of cardiac sympathetic denervation and diagnostic value.J Nucl Med 1999; 40: 371\u2013375.","journal-title":"J Nucl Med"},{"key":"BF02984560_CR53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","volume":"133","author":"DS Goldstein","year":"2000","unstructured":"Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO, 3rd. Cardiac sympathetic denervation in Parkinson disease.Ann Intern Med 2000; 133: 338\u2013347.","journal-title":"Ann Intern Med"},{"key":"BF02984560_CR54","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1161\/01.CIR.85.5.1775","volume":"85","author":"G Eisenhofer","year":"1992","unstructured":"Eisenhofer G, Esler MD, Meredith IT, Dart A, Cannon RO 3rd, Quyyumi AA, et al. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxy-phenylglycol and norepinephrine.Circulation 1992; 85: 1775\u20131785.","journal-title":"Circulation"},{"key":"BF02984560_CR55","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/jnnp.57.6.672","volume":"57","author":"CD Marsden","year":"1994","unstructured":"Marsden CD. Parkinson\u2019s disease.J Neurol Neurosurg Psychiatry 1994; 57: 672\u2013681.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR56","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1212\/WNL.42.6.1142","volume":"42","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson\u2019s disease: a clinicopathologic study.Neurology 1992; 42: 1142\u20131146.","journal-title":"Neurology"},{"key":"BF02984560_CR57","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases.J Neurol Neurosurg Psychiatry 1992; 55: 181\u2013184.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1001\/archneur.1993.00540020018011","volume":"50","author":"AJ Hughes","year":"1993","unstructured":"Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson\u2019s disease.Arch Neurol 1993; 50: 140\u2013148.","journal-title":"Arch Neurol"},{"key":"BF02984560_CR59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.64.2.184","volume":"64","author":"GK Wenning","year":"1998","unstructured":"Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination.J Neurol Neurosurg Psychiatry 1998; 64: 184\u2013189.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR60","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s002590050548","volume":"27","author":"MJ Reinhardt","year":"2000","unstructured":"Reinhardt MJ, Jungling FD, Krause TM, Braune S. Scinti-graphic differentiation between two forms of primary dys-autonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake.Eur J Nucl Med 2000; 27: 595\u2013600.","journal-title":"Eur J Nucl Med"},{"key":"BF02984560_CR61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jama.284.1.39","volume":"284","author":"H Takatsu","year":"2000","unstructured":"Takatsu H, Nagashima K, Murase M, Fujiwara H, Nishida H, Matsuo H, et al. Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation.JAMA 2000; 284: 44\u201345.","journal-title":"JAMA"},{"key":"BF02984560_CR62","doi-asserted-by":"crossref","unstructured":"Jellinger K, Riederer P, Tomonaga M. Progressive supra-nuclear palsy: clinico-pathological and biochemical studies.J Neural Transm Suppl 1980: 111\u2013128.","DOI":"10.1007\/978-3-7091-8582-7_12"},{"key":"BF02984560_CR63","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/1531-8257(199911)14:6<947::AID-MDS1006>3.0.CO;2-O","volume":"14","author":"GK Wenning","year":"1999","unstructured":"Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, JellingerK McKee A, et al. Progression of falls in postmortem-confirmed parkinsonian disorders.Mov Disord 1999; 14: 947\u2013950.","journal-title":"Mov Disord"},{"key":"BF02984560_CR64","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2169\/internalmedicine.42.127","volume":"42","author":"S Orimo","year":"2003","unstructured":"Orimo S, Ozawa E, Nakade S, Hattori H, Tsuchiya K, Taki K, et al. [123I] meta-iodobenzylguanidine myocardial scintigraphy differentiates corticobasal degeneration from Parkinson\u2019s disease.Intern Med 2003; 42: 127\u2013128.","journal-title":"Intern Med"},{"key":"BF02984560_CR65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1474-4422(03)00619-7","volume":"3","author":"I McKeith","year":"2004","unstructured":"McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies.Lancet Neurol 2004; 3: 19\u201328.","journal-title":"Lancet Neurol"},{"key":"BF02984560_CR66","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1212\/WNL.53.5.902","volume":"53","author":"IG McKeith","year":"1999","unstructured":"McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.Neurology 1999; 53: 902\u2013905.","journal-title":"Neurology"},{"key":"BF02984560_CR67","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jnnp.71.5.583","volume":"71","author":"M Yoshita","year":"2001","unstructured":"Yoshita M, Taki J, Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer\u2019s-type and dementia with Lewy bodies.J Neurol Neurosurg Psychiatry 2001; 71: 583\u2013588.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR68","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jnnp.70.6.781","volume":"70","author":"H Watanabe","year":"2001","unstructured":"Watanabe H, Ieda T, Katayama T, Takeda A, Aiba I, Doyu M, et al. Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer\u2019s disease.J Neurol Neurosurg Psychiatry 2001; 70: 781\u2013783.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF02984560_CR69","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2169\/internalmedicine.42.686","volume":"42","author":"T Oide","year":"2003","unstructured":"Oide T, Tokuda T, Momose M, Oguchi K, Nakamura A, Ohara S, et al. Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer\u2019s disease and dementia with Lewy bodies.Intern Med 2003; 42: 686\u2013690.","journal-title":"Intern Med"},{"key":"BF02984560_CR70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00401-002-0651-4","volume":"105","author":"N Hishikawa","year":"2003","unstructured":"Hishikawa N, Hashizume Y, Yoshida M, Sobue G. Clinical and neuropathological correlates of Lewy body disease.Acta Neuropathol (Beri) 2003; 105: 341\u2013350.","journal-title":"Acta Neuropathol (Beri)"},{"key":"BF02984560_CR71","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0165-1838(95)00002-F","volume":"53","author":"M Hirayama","year":"1995","unstructured":"Hirayama M, Hakusui S, Koike Y, Ito Kato T, Ikeda M, et al. A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[l23I]iodobenzyl-guanidine in neurological patients with autonomie failure.J Auton Nerv Syst 1995; 53: 230\u2013234.","journal-title":"J Auton Nerv Syst"},{"key":"BF02984560_CR72","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000113396","volume":"38","author":"M Yoshida","year":"1997","unstructured":"Yoshida M, Fukumoto Y, Kuroda Y, Ohkoshi N. Sympathetic denervation of myocardium demonstrated by123I-MIBG scintigraphy in pure progressive autonomie failure.Eur Neurol 1997; 38: 291\u2013296.","journal-title":"Eur Neurol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02984560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02984560\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02984560","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T23:35:52Z","timestamp":1589067352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02984560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["BF02984560"],"URL":"https:\/\/doi.org\/10.1007\/bf02984560","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}